NCT01245140 - Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 26, 2011

Primary Completion Date

March 12, 2014

Study Completion Date

April 16, 2014

Conditions

Psoriasis

Interventions

DRUG

alitretinoin

to receive verum (20 patients)

DRUG

Placebo

to receive placebo (10 patients)

Trial Locations (8)

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Hamburg

GSK Investigational Site, Witten

GSK Investigational Site, Paris

GSK Investigational Site, Munich

GSK Investigational Site, Nijmegen

GSK Investigational Site, London